Mitomycin as a Hyperthermic Peritoneal Perfusion in Treating Patients With Malignant Ascites
- First Posted Date
- 2005-12-15
- Last Posted Date
- 2017-11-29
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 1
- Registration Number
- NCT00265863
- Locations
- 🇺🇸
University of Minnesota Cancer Center, Minneapolis, Minnesota, United States
Chemoradiation in Locally Advanced Pancreatic Cancer
Phase 2
Terminated
- Conditions
- Pancreatic Cancer
- Interventions
- Biological: recombinant interferon alfaRadiation: radiation therapyProcedure: Resection of tumor
- First Posted Date
- 2005-12-07
- Last Posted Date
- 2017-12-28
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 23
- Registration Number
- NCT00262951
- Locations
- 🇺🇸
Masonic Cancer Center at University of Minnesota, Minneapolis, Minnesota, United States
Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia
Phase 2
Completed
- Conditions
- Fanconi Anemia
- Interventions
- Biological: anti-thymocyte globulinBiological: filgrastimBiological: Hematopoietic stem cell transplantation
- First Posted Date
- 2005-11-24
- Last Posted Date
- 2021-12-02
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 14
- Registration Number
- NCT00258427
- Locations
- 🇺🇸
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer
Phase 2
Completed
- Conditions
- Endometrial Cancer
- Interventions
- First Posted Date
- 2005-11-24
- Last Posted Date
- 2017-12-28
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 41
- Registration Number
- NCT00258362
- Locations
- 🇺🇸
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
🇺🇸Park Nicollet Cancer Center, Saint Louis Park, Minnesota, United States
Stem Cell Transplant for Bone Marrow Failure Syndromes
Phase 2
Completed
- Conditions
- Diamond-Blackfan AnemiaKostmann's NeutropeniaShwachman-Diamond Syndrome
- Interventions
- Procedure: Stem cell transplantProcedure: Total lymphoid irradiationBiological: anti-thymocyte globulin
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2017-12-28
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 10
- Registration Number
- NCT00176878
- Locations
- 🇺🇸
University of Minnesota Medical Center, Minneapolis, Minnesota, United States
Stem Cell Transplant for Hemoglobinopathy
Phase 2
Completed
- Conditions
- Diamond-Blackfan AnemiaThalassemiaShwachman-Diamond SyndromeSickle Cell DiseaseSevere Congenital Neutropenia
- Interventions
- Drug: Busulfan, Cyclophosphamide, ATG, GCSFDrug: Busulfan, Fludarabine, ATG, TLIRadiation: Total Body IrradiationProcedure: Stem cell infusion
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2020-02-27
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 22
- Registration Number
- NCT00176852
- Locations
- 🇺🇸
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
Stem Cell Transplantation for Hurler
Phase 2
Completed
- Conditions
- Mucopolysaccharidosis IMucolipidosis Type II (I-cell Disease)MannosidosisMucopolysaccharidosis VI
- Interventions
- Procedure: Stem Cell TransplantDrug: Busulfan, Cyclophosphamide, ATG
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2017-12-28
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 41
- Registration Number
- NCT00176917
- Locations
- 🇺🇸
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders
Phase 2
Terminated
- Conditions
- Hemophagocytic LymphohistiocytosisX-Linked Lymphoproliferative DisordersChediak-Higashi SyndromeGriscelli SyndromeImmunologic DiseasesLangerhans-Cell HistiocytosisHematologic Diseases
- Interventions
- Procedure: Stem Cell TransplantDrug: Myeloablative conditioning regimen
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 22
- Registration Number
- NCT00176826
- Locations
- 🇺🇸
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
Stem Cell Transplantation for Hematological Malignancies
Phase 2
Terminated
- Conditions
- Leukemia, Lymphocytic, AcuteAMLMDS
- Interventions
- Procedure: Stem Cell Transplant
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2017-12-05
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 11
- Registration Number
- NCT00176839
- Locations
- 🇺🇸
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
Stem Cell Transplant for Inborn Errors of Metabolism
Phase 2
Completed
- Conditions
- Metachromatic LeukodystrophyBatten DiseaseGM1 GangliosidosisTay Sachs DiseaseSandhoff DiseaseAdrenoleukodystrophyGloboid Cell LeukodystrophyGaucher's DiseaseFucosidosisWolman Disease
- Interventions
- Procedure: Stem Cell TransplantDrug: Busulfan, Cyclophosphamide, Antithymocyte Globulin
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2017-12-28
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 135
- Registration Number
- NCT00176904
- Locations
- 🇺🇸
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
© Copyright 2025. All Rights Reserved by MedPath